✦ LIBER ✦

Advanced gastric cancer successfully resected following cisplatin therapy: Report of a case

✍ Scribed by Shigetoyo Saji; Yasushi Kishimoto; Kazuki Sakata; Tomohiko Furuta; Hiromi Tanemura; Ryo Kawata

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 664 KB
Volume: 36
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930360214

No coin nor oath required. For personal study only.

✦ Synopsis

A case of unresectable advanced gastric cancer was treated with cisdichlorodiammine platinum (CDDP) at a dosage of 30 mg/day for 5 days every month after operation. After three courses of administration, examinations revealed that the tumor had disappeared, and an evaluation of complete response was made. Four months later, a second-look operation was performed; and it was found that the cancer was smaller than a thumb and could be resected radically. No significant side effects were observed during CDDP therapy.

📜 SIMILAR VOLUMES

A phase ii study of the combination of e

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

A phase II study of combination therapy

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

✍ Wasaburo Koizumi; Minoru Kurihara; Tadashi Sasai; Shigeaki Yoshida; Kimitomo Mor 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Background. 5'-Deoxy-5-fluorouridine (5'-DFUR, doxifluridine) is a recently developed prodrug of oral From the Japan Gastric Cancer Study Group,

Efficacy of prolonged intermittent thera

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

✍ Dr. George A. Higgins; Jose H. Amadeo; Dan E. Smith; Edward W. Humphrey; Robert 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 679 KB

A randomized phase 2 study of docetaxel

A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy

✍ Hei-Cheul Jeung; Sun Young Rha; Chong Kun Im; Sang Joon Shin; Joong Bae Ahn; Woo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Ten-year follow-up of a phase 2 study of

Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer

✍ Gisele A. Sarosy; Mahrukh M. Hussain; Michael V. Seiden; Arlan F. Fuller; Najmos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND: The objective of this study was to assess activity and toxicity in patients with newly diagnosed, advanced‐stage epithelial ovarian cancer (EOC) who were receiving dose‐intense paclitaxel, cyclophosphamide, cisplatin, and filgrastim delivered with a flexible dosing sched